BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu M, Li L, Lu T, Yoo H, Zhu J, Gopal P, Wang SC, Porembka MR, Rich NE, Kagan S, Odewole M, Renteria V, Waljee AK, Wang T, Singal AG, Yopp AC, Zhu H. Uncovering Biological Factors That Regulate Hepatocellular Carcinoma Growth Using Patient-Derived Xenograft Assays. Hepatology 2020;72:1085-101. [PMID: 31899548 DOI: 10.1002/hep.31096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Xian L, Zhao P, Chen X, Wei Z, Ji H, Zhao J, Liu W, Li Z, Liu D, Han X, Qian Y, Dong H, Zhou X, Fan J, Zhu X, Yin J, Tan X, Jiang D, Yu H, Cao G. Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer. Cell Oncol (Dordr) 2022. [PMID: 36036881 DOI: 10.1007/s13402-022-00707-3] [Reference Citation Analysis]
2 Karalis JD, Yoon LY, Hammer STG, Hong C, Zhu M, Nassour I, Ju MR, Xiao S, Castro-dubon EC, Agrawal D, Suarez J, Reznik SI, Mansour JC, Polanco PM, Yopp AC, Zeh HJ, Hwang TH, Zhu H, Porembka MR, Wang SC. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03317-7] [Reference Citation Analysis]
3 Zou C, El Dika I, Vercauteren KOA, Capanu M, Chou J, Shia J, Pilet J, Quirk C, Lalazar G, Andrus L, Kabbani M, Yaqubie A, Khalil D, Mergoub T, Chiriboga L, Rice CM, Abou‐alfa GK, de Jong YP. Mouse characteristics that affect establishing xenografts from hepatocellular carcinoma patient biopsies in the United States. Cancer Medicine. [DOI: 10.1002/cam4.4375] [Reference Citation Analysis]
4 Zhuo J, Lu D, Lin Z, Yang X, Yang M, Wang J, Tao Y, Wen X, Li H, Lian Z, Cen B, Dong S, Wei X, Xie H, Zheng S, Shen Y, Xu X. The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib. Cell Death Dis 2021;12:1084. [PMID: 34785656 DOI: 10.1038/s41419-021-04320-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Tanaka T, Nishie R, Ueda S, Miyamoto S, Hashida S, Konishi H, Terada S, Kogata Y, Sasaki H, Tsunetoh S, Taniguchi K, Komura K, Ohmichi M. Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review. Int J Mol Sci 2021;22:9369. [PMID: 34502278 DOI: 10.3390/ijms22179369] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 He X, Sun H, Jiang Q, Chai Y, Li X, Wang Z, Zhu B, You S, Li B, Hao J, Xin S. Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4. Front Oncol 2021;11:735447. [PMID: 34381736 DOI: 10.3389/fonc.2021.735447] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
7 Li Q, Ni Y, Zhang L, Jiang R, Xu J, Yang H, Hu Y, Qiu J, Pu L, Tang J, Wang X. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Signal Transduct Target Ther 2021;6:76. [PMID: 33619246 DOI: 10.1038/s41392-020-00453-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zhu S, Kubota N, Hoshida Y. Transcriptome-Guided Design of Physiological Multilineage Liver Organoids. Trends Genet 2021;37:403-4. [PMID: 33541711 DOI: 10.1016/j.tig.2021.01.007] [Reference Citation Analysis]
9 Colemonts-Vroninks H, Neuckermans J, Marcelis L, Claes P, Branson S, Casimir G, Goyens P, Martens GA, Vanhaecke T, De Kock J. Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation. Genes (Basel) 2020;12:E3. [PMID: 33375092 DOI: 10.3390/genes12010003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Cho SY. Patient-derived xenografts as compatible models for precision oncology. Lab Anim Res 2020;36:14. [PMID: 32461927 DOI: 10.1186/s42826-020-00045-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]